Mitral valve leaflet clipping in patients with previously implanted heart failure devices
https://doi.org/10.38109/2225-1685-2024-3-28-34
Abstract
Introduction. Modern clinical guidelines for heart failure consider a comprehensive approach to treatment using implantation of various devices (cardiac resynchronisation therapy CRT, implantation of cardioverter-defibrillator (ICD), installation of pacemakers (ECS) as well as correction of valve defects. For example, for treatment of severe mitral valve insufficiency the technique of clipping its flaps using MitraClip system is used.
Objective. To evaluate the effect of mitral valve intervention with the help of MitraClip on the course of chronic heart failure (CHF) in patients with implanted devices.
Materials and Methods. 73 patients with mitral regurgitation of 3-4 degree, heart failure of II-IV NYHA functional class who underwent implantation of MitraClip system on mitral valve flaps were included in the study. The dynamics of EchoCG parameters, exercise tolerance, diuretic therapy and brain natriuretic pro-peptide level was evaluated during six months. The comparison of the results of follow-up of the group of patients who had previously been fitted with ECS, ICD, CRT (group A) with the data of patients without implanted devices (group B) was carried out.
Results. Clinical improvement of the course of CCN occurred after 6 months in both observation groups. The mean functional class (FC) of CHF decreased in group A from 2.67 ± 0.8 to 1.81 ± 0.7 (p<0.001) and in group B from 2.72 ± 1.97 (p < 0.001) to 1.86 ± 0.6, exercise tolerance increased significantly (6-minute walk test distance values increased from 299 [178; 340] m to 390 [231.3; 420] m and 235.5 [182.8; 370.3] m (p = 0.04) to 362.3 [270; 412.7] m (p = 0.03), respectively. EchoCG analysis in both groups showed no dynamics of myocardial contractility. In group A there was an increase in stroke volume (SV) from 44 [37; 63] ml to 58.5 [49.5; 84.3] ml (p = 0.03) and a decrease in pulmonary artery pressure (PAP) from 44 [35; 62.5] mm Hg to 39 [29.8; 45] mm Hg (p = 0.02). In group B, in addition to an increase in SV from 57.5 [48.8; 65.3] ml to 61 [52; 74.5] ml (p = 0.03) and a decrease in PAP from 45 [36.5; 59.3] mm Hg to 32 [27.3; 43.5] mm Hg (p < 0.001), an increase in cardiac output (CO) from 4 [3.3; 4.8] L/min to 4.5 [3.6; 5.3] L/min (p = 0.04) and a significant decrease in left atrial and left ventricular dimensions and volumes were obtained.
Conclusion. Application of the system of MC leaflet clipping for correction of severe MR leads to improvement of clinical condition in patients with CHF both with and without implanted devices. Absence of significant dynamics of heart chamber sizes and volumes according to EchoCG data in patients with implanted devices is most likely due to small sample size.
Supporting agencies: The work was carried out without attracting additional funding from third parties
About the Authors
Ya. Sh. Karamova
E.I. Chazov National Medical Research Center of Cardiology
Russian Federation
Russian Federation
Yana Sh. Karamova
121552; 5A Akademika Chazovа st.; Mosсow
T. M. Uskach
E.I. Chazov National Medical Research Center of Cardiology; Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
Tatiana M. Uskach
121552; 5A Akademika Chazovа st.; 125993; BarrIkadnaya st., 2/1, BuIldIng 1; Mosсow
T. E. Imaev
E.I. Chazov National Medical Research Center of Cardiology; Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
Timur E. Imaev
121552; 5A Akademika Chazovа st.; 125993; BarrIkadnaya st., 2/1, BuIldIng 1; Mosсow
S. N. Tereshchenko
E.I. Chazov National Medical Research Center of Cardiology
Russian Federation
Russian Federation
Sergey N. Tereshchenko
121552; 5A Akademika Chazovа st.; Mosсow
References
1. McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., Cleland, J. G. F., Coats, A. J. S., Crespo-Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A., Lainscak, M., … ESC Scientific Document Group (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 42(36), 3599–3726. doi: 10.1093/eurheartj/ehab368
2. Asgar, A. W., Mack, M. J., & Stone, G. W. (2015). Secondary mitral regurgitation in heart failure: Pathophysiology, prognosis, and therapeutic considerations. Journal of the American College of Cardiology, 65(12), 1231-1248. doi: 10.1016/j.jacc.2015.02.009
3. Iung, B., & Vahanian, A. (2014). Epidemiology of acquired valvular heart disease. The Canadian journal of cardiology, 30(9), 962–970. doi: 10.1016/j.cjca.2014.03.022
4. Geis, N.A.; Göbbel, A.; Kreusser, M.M.; Täger, T.; Katus, H.A.; Frey, N.; Schlegel, P.; Raake, P.W. Impact of Percutaneous Mitral Valve Repair Using the MitraClipTM System on Ventricular Arrhythmias and ICD Therapies. Life 2022, 12, 344. doi: 10.3390/life12030344
5. Cahill, T. J., Prothero, A., Wilson, J., Kennedy, A., Brubert, J., Masters, M., Newton, J. D., Dawkins, S., Enriquez-Sarano, M., Prendergast, B. D., & Myerson, S. G. (2021). Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation. Heart (British Cardiac Society), heartjnl-2020-318482. doi: 10.1136/heartjnl-2020-318482
6. Kienemund, J., Kuck, K. H., & Frerker, C. (2014). Cardiac Resynchronisation Therapy or MitraClip® Implantation for Patients with Severe Mitral Regurgitation and Left Bundle Branch Block. Arrhythmia & electrophysiology review, 3(3), 190–193. doi: 10.15420/aer.2014.3.3.190
7. Kosmidou, I., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Kipperman, R. M., Boudoulas, K. D., Redfors, B., Shahim, B., Zhang, Z., Mack, M. J., & Stone, G. W. (2020). Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial. Circulation. Heart failure, 13(11), e007293. doi: 10.1161/CIRCHEARTFAILURE.120.007293
8. D'Ancona, G., Ince, H., Schillinger, W., Senges, J., Ouarrak, T., Butter, C., Seifert, M., Schau, T., Lubos, E., Boekstegers, P., von Bardeleben, R. S., & Safak, E. (2019). Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry). Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions, 94(5), 755–763. doi: 10.1002/ccd.28127.
Review
For citations:
Karamova Ya.Sh., Uskach T.M., Imaev T.E., Tereshchenko S.N. Mitral valve leaflet clipping in patients with previously implanted heart failure devices. Eurasian heart journal. 2024;(3):28-34. (In Russ.) https://doi.org/10.38109/2225-1685-2024-3-28-34
Views:
258
Email this article 
